---
document_datetime: 2025-11-23 13:11:52
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/raptiva.html
document_name: raptiva.html
version: success
processing_time: 0.1012888
conversion_datetime: 2025-12-24 19:25:35.280186
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Raptiva

[RSS](/en/individual-human-medicine.xml/65948)

##### Withdrawn

This medicine's authorisation has been withdrawn

efalizumab

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 20 September 2004 the European Commission granted a marketing authorisation valid throughout the European Union for the medicinal product Raptiva (efalizumab), indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who have failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapies including cyclosporin, methotrexate and PUVA.

On 19 February 2009, the Committee for Medicinal Products for Human Use (CHMP) issued an Opinion recommending the suspension of the marketing authorisation for Raptiva in all Member States in which the product was marketed, as its benefits in the treatment of psoriasis were modest, while there was a risk of serious side effects, including the occurrence of progressive multifocal leukoencephalopathy (PML). As a condition for lifting the suspension, the CHMP recommended that new evidence should be provided to identify a subgroup of patients for which the benefits of Raptiva would outweigh the risks. On 12 May 2009, the Marketing Authorisation Holder for Raptiva (Serono Europe Limited) notified the European Commission of its decision to voluntarily withdraw the marketing authorisation for the product, as it did not intend to conduct the clinical trials necessary to fulfil the requirements for lifting the suspension.

On 9 June 2009 the European Commission issued a decision to withdraw the marketing authorisation for Raptiva. Pursuant to this decision the European Public Assessment Report for Raptiva is updated to reflect that the marketing authorisation is no longer valid.

Raptiva : EPAR - Summary for the public

English (EN) (476.19 KB - PDF)

**First published:** 04/08/2009

**Last updated:** 04/08/2009

[View](/en/documents/overview/raptiva-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-399)

български (BG) (652.34 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/bg/documents/overview/raptiva-epar-summary-public_bg.pdf)

español (ES) (480.9 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/es/documents/overview/raptiva-epar-summary-public_es.pdf)

čeština (CS) (621.87 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/cs/documents/overview/raptiva-epar-summary-public_cs.pdf)

dansk (DA) (479.96 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/da/documents/overview/raptiva-epar-summary-public_da.pdf)

Deutsch (DE) (482.21 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/de/documents/overview/raptiva-epar-summary-public_de.pdf)

eesti keel (ET) (479.53 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/et/documents/overview/raptiva-epar-summary-public_et.pdf)

ελληνικά (EL) (648.48 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/el/documents/overview/raptiva-epar-summary-public_el.pdf)

français (FR) (482.85 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/fr/documents/overview/raptiva-epar-summary-public_fr.pdf)

italiano (IT) (479.99 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/it/documents/overview/raptiva-epar-summary-public_it.pdf)

latviešu valoda (LV) (630.86 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/lv/documents/overview/raptiva-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (597.18 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/lt/documents/overview/raptiva-epar-summary-public_lt.pdf)

magyar (HU) (612.63 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/hu/documents/overview/raptiva-epar-summary-public_hu.pdf)

Malti (MT) (625.45 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/mt/documents/overview/raptiva-epar-summary-public_mt.pdf)

Nederlands (NL) (481.05 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/nl/documents/overview/raptiva-epar-summary-public_nl.pdf)

polski (PL) (634.88 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/pl/documents/overview/raptiva-epar-summary-public_pl.pdf)

português (PT) (480.46 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/pt/documents/overview/raptiva-epar-summary-public_pt.pdf)

română (RO) (590.34 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/ro/documents/overview/raptiva-epar-summary-public_ro.pdf)

slovenčina (SK) (616.96 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/sk/documents/overview/raptiva-epar-summary-public_sk.pdf)

slovenščina (SL) (608.71 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/sl/documents/overview/raptiva-epar-summary-public_sl.pdf)

Suomi (FI) (480.01 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/fi/documents/overview/raptiva-epar-summary-public_fi.pdf)

svenska (SV) (479.71 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/sv/documents/overview/raptiva-epar-summary-public_sv.pdf)

## Product information

Raptiva : EPAR - Product Information

English (EN) (850.76 KB - PDF)

**First published:** 04/08/2009

**Last updated:** 04/08/2009

[View](/en/documents/product-information/raptiva-epar-product-information_en.pdf)

[Other languages (21)](#file-language-dropdown-31)

български (BG) (1.14 MB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/bg/documents/product-information/raptiva-epar-product-information_bg.pdf)

español (ES) (878.47 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/es/documents/product-information/raptiva-epar-product-information_es.pdf)

čeština (CS) (1007.55 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/cs/documents/product-information/raptiva-epar-product-information_cs.pdf)

dansk (DA) (871.66 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/da/documents/product-information/raptiva-epar-product-information_da.pdf)

Deutsch (DE) (881.66 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/de/documents/product-information/raptiva-epar-product-information_de.pdf)

eesti keel (ET) (884.34 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/et/documents/product-information/raptiva-epar-product-information_et.pdf)

ελληνικά (EL) (1.2 MB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/el/documents/product-information/raptiva-epar-product-information_el.pdf)

français (FR) (896.73 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/fr/documents/product-information/raptiva-epar-product-information_fr.pdf)

italiano (IT) (897.76 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/it/documents/product-information/raptiva-epar-product-information_it.pdf)

latviešu valoda (LV) (1.05 MB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/lv/documents/product-information/raptiva-epar-product-information_lv.pdf)

lietuvių kalba (LT) (943.07 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/lt/documents/product-information/raptiva-epar-product-information_lt.pdf)

magyar (HU) (950.16 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/hu/documents/product-information/raptiva-epar-product-information_hu.pdf)

Malti (MT) (968.62 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/mt/documents/product-information/raptiva-epar-product-information_mt.pdf)

Nederlands (NL) (901.28 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/nl/documents/product-information/raptiva-epar-product-information_nl.pdf)

polski (PL) (1.02 MB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/pl/documents/product-information/raptiva-epar-product-information_pl.pdf)

português (PT) (870.26 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/pt/documents/product-information/raptiva-epar-product-information_pt.pdf)

română (RO) (998.17 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/ro/documents/product-information/raptiva-epar-product-information_ro.pdf)

slovenčina (SK) (987.12 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/sk/documents/product-information/raptiva-epar-product-information_sk.pdf)

slovenščina (SL) (947.76 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/sl/documents/product-information/raptiva-epar-product-information_sl.pdf)

Suomi (FI) (857.16 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/fi/documents/product-information/raptiva-epar-product-information_fi.pdf)

svenska (SV) (885.96 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/sv/documents/product-information/raptiva-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** II/0026 25/11/2008

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Raptiva : EPAR - All Authorised presentations

English (EN) (435.6 KB - PDF)

**First published:** 04/08/2009

**Last updated:** 04/08/2009

[View](/en/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-266)

български (BG) (534.58 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/bg/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_bg.pdf)

español (ES) (436.67 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/es/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_es.pdf)

čeština (CS) (530.28 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/cs/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (436.5 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/da/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (436.65 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/de/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (436.4 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/et/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (530.84 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/el/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_el.pdf)

français (FR) (436.52 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/fr/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (436.31 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/it/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (529.38 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/lv/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (465.41 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/lt/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (496.14 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/hu/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (523.94 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/mt/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (435.94 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/nl/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_nl.pdf)

polski (PL) (529.04 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/pl/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_pl.pdf)

português (PT) (436.74 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/pt/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_pt.pdf)

română (RO) (500.88 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/ro/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (525.99 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/sk/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (487.79 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/sl/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (436.31 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/fi/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (436.74 KB - PDF)

**First published:**

04/08/2009

**Last updated:**

04/08/2009

[View](/sv/documents/all-authorised-presentations/raptiva-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Raptiva Active substance efalizumab International non-proprietary name (INN) or common name efalizumab Therapeutic area (MeSH) Psoriasis Anatomical therapeutic chemical (ATC) code L04AA21

### Pharmacotherapeutic group

Immunosuppressants

### Therapeutic indication

Treatment of adult patients with moderate to severe chronic plaque psoriasis who have failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapies including ciclosporin, methotrexate and PUVA (see section 5.1 - Clinical Efficacy).

## Authorisation details

EMA product number EMEA/H/C/000542 Marketing authorisation holder

Serono Europe Limited

Serono Europe Ltd.

Marketing authorisation issued 20/09/2004 Withdrawal of marketing authorisation 09/06/2009 Revision 8

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Raptiva : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (536.08 KB - PDF)

**First published:** 04/08/2009

**Last updated:** 04/08/2009

[View](/en/documents/procedural-steps-after/raptiva-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Raptiva-H-542-A20-28-SC : EPAR - Scientific Conclusion

Reference Number: EMEA/83006/2009

English (EN) (497.96 KB - PDF)

**First published:** 04/08/2009

**Last updated:** 04/08/2009

[View](/en/documents/scientific-conclusion/raptiva-h-542-a20-28-sc-epar-scientific-conclusion_en.pdf)

Raptiva-H-C-542-II-19 : EPAR - Assessment Report - Variation

Reference Number: EMEA/112794/2009

English (EN) (645.96 KB - PDF)

**First published:** 04/08/2009

**Last updated:** 04/08/2009

[View](/en/documents/variation-report/raptiva-h-c-542-ii-19-epar-assessment-report-variation_en.pdf)

## Initial marketing authorisation documents

Raptiva : EPAR - Procedural steps taken before authorisation

English (EN) (521.41 KB - PDF)

**First published:** 04/08/2009

**Last updated:** 04/08/2009

[View](/en/documents/procedural-steps/raptiva-epar-procedural-steps-taken-authorisation_en.pdf)

Raptiva : EPAR - Scientific Discussion

English (EN) (1.17 MB - PDF)

**First published:** 04/08/2009

**Last updated:** 04/08/2009

[View](/en/documents/scientific-discussion/raptiva-epar-scientific-discussion_en.pdf)

**This page was last updated on** 04/08/2009

## Share this page

[Back to top](#main-content)